ESK-1

N/A

Report date: 2023/01/04 13:57:12

Base Information

Drug NameESK-1
Drug Alias NameESK-1
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionTranscription factors modulatorsAntibody-dependent cell-mediated cytotoxicity (ADCC) effects
TargetsTranscription factors
Therapy Area/IndicationsSolid tumoursHematologic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMemorial Sloan Kettering Cancer CenterEureka Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesNovartis Pharma AgEureka Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursHematologic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A